Poster Presentations

Organization
Primary Author and Poster Title
Aptar Pharma
Goncalo Farias
Development of a Novel Device Targeting Drug Delivery into the Olfactory Region of the Nasal Cavity
PF
Aptar Pharma
Jose Ferrao and Pauline Faucard
Leachables Assessment from a New Generation of pMDI Using Low Global Warming Potential Propellants
GD
Aptar Pharma
Gerallt Williams and Gregoire Deraime
Filling and Dose Performance of pMDIs with New Low Global Warming Potential Propellants
JK
Aston Particle Technologies
David Wyatt and Jasdip Koner
Use of Isothermal Dry Particle Coating (iDPC) for the Development of High Dose Dry Powder Inhalers
AstraZeneca
Kellisa Lachacz and David Lechuga
Comparative Aerosol Performance of an HFA-134a Based Fixed-Dose Triple Combination pMDI to One Made with HFO-1234ze - a Near-Zero Carbon Footprint Propellant
KV
AstraZeneca
David Lechuga and Kou Vang
Drug Delivery Evaluation of AIRSUPRA™, a Fixed-Dose SABA/ICS Co-Suspension Delivery Technology Combination MDI
AstraZeneca
David Lechuga
Quadruple Combination in a Pressurized Metered Dose Inhaler with Reduced Environmental Impact for the Treatment of COPD
KY
Battelle
Kevin Yugulis
Use of Computational Fluid Dynamics Simulations for Localized Deposition Assessment of Inhaled Particles
Catalent
Alan Watts
Particle Re-entrainment and Wall Loss Reduction Through Utilization of Aqueous Plate Coating in the Next Generation Impactor
MB
DFE Pharma
Maribel Bogalo Huescar
Impact of Active Pharmaceutical Ingredient Span and the Amount of Lactose Fines on Dry Powder Inhaler Formulation Performance
MM
Harro Höfliger
Karin Marek and Mohit Mehta
Understanding the Impact of In-Line Sieving on the Filling Behavior of Different Inhalation Powders Using Drum Filling Technology
Honeywell
Gregory Smith
HFO-1234ze(E): Flammability Characterization for Metered Dose Inhaler Manufacturing
Hovione
Maria Lopes
On the Use of Process Analytical Technology to Expedite Spray Dried DPI Formulations
Insmed
Zhili Li
Performance of Treprostinil Palmitil Inhalation Powder (TPIP) Delivery System
Kindeva Drug Delivery
James McNeill
Development of a Particle Sizing Methodology for Early Screening of Carrier-Based DPI Formulations using Laser Diffraction
DROB
Kindeva Drug Delivery
David Riley and Olivia Brittain
An Evaluation of Solution and Suspension pMDIs Containing HFA152a and HFO1234ze Using Clinically Relevant Test Methods
JM
Koura
James Murray
Anti-Microbial Properties of Low-GWP pMDI Propellant P-152a
Lonza
Kimberly Shepard
Room Temperature 24-Month Stability of Spray-Dried Bevacizumab Formulation for Dry Powder Inhaler
Lund University
Kyrre Thalberg
The Effect of Mixing on the Dispersibility of Adhesive Mixtures for Inhalation
M2M Pharmaceuticals
Mridul Majumder
Chemical Imaging by Raman Spectrometer for Particle Characterization of an Aqueous Nasal Spray
Micro-Sphere SA
Rodrigo Amorim
Production of Amorphous Solid Dispersions at Low Temperature by Electrostatic Spray Drying: Delivery of Thermolabile Compounds with Enhanced Bioavailability
Monash University
Jason Brenker
Microfluidic Aerosol Generation: Breaking Free from Capillary Wave Theory
Nanoform
Barry Derham
Budesonide Nanocrystal Manufacturing Using Controlled Expansion of Supercritical Solutions (CESS®)
Nanopharm
Will Ganley
Using a Physiologically Based Pharmacokinetic Model to Investigate the Relationship Between Device, Orientation, Deposition Pattern and the Systemic Exposure of Sumatriptan Nasal Solutions
AZ
Nanopharm
Irene Rossi and Antonia Zapata
Assessment of the Realistic Performance of Orbital™ Device Loaded with Model Fluticasone Proprionate Blends Manufactured by Low Shear and Isothermal Dry Particle Coating
Nanopharm
Irene Rossi and Paul Shields
Formulation Technologies Assessment for the Development of Intranasal Powders Comprising a Peptide
EM
Nebu-Flow
Elspeth Macdonald
Tuneable Nebulizer Platform for Targeted Inhalation Drug Delivery
Oz-UK Limited
David Lewis
HFA152a MDI Design: Matching the In Vitro Performance of HFA227ea and HFA134a MDIs
Oz-UK Limited
David Lewis
Towards Pharmaceutical Equivalence: A Comparison of Three MDIs: HFA152a, HFA134a, and HFA227ea
KS
PARI Pharma
Andrea Winzen and Karin Steinfuehrer
Development of a Pediatric Upper Airway Model as Add-on for a High Repeatability Test Stand for the Measurement of Valved Holding Chambers
Proveris Scientific Corporation
Lynn Jordan
Comparison of Spray Characteristics of P-134a and Low GWP P-152a pMDIs With and Without Ethanol
Recipharm
Sabrina Falloon and Adam Gibbons
Usability Evaluation of a Novel, User-Independent Unit Dose Nasal Spray via Human Factors Studies
Recipharm
Lei Mao
Albuterol Sulfate Metered Dose Inhaler Feasibility Using an Environment Friendly Propellant HFA152a and Novel Valves
Recipharm
Benjamin Thorne
Comparison of Simulated pMDI Droplet Sizes of Fluticasone Propionate Suspension and Solution Formulations to Next Generation Impactor Data
Solvias
Yannick Baschung
Effect of Capsule-Based Dry Powder Inhaler User Training on In Vitro Performance
South East Technological University
Nasser Alhajj
Development and Characterization of a Spray-Dried Inhalable Ciprofloxacin-Quercetin Co-Amorphous System Against Pseudomonas Aeruginosa Biofilms
AW
Team Consulting
Prem-Sagar Tank and Alastair Willoughby
Evolving Strategies for Designing a Sustainable Inhaler
Trudell Medical International
Mark Nagel and Jolyon Mitchell
Does Replacing an Electromechanical ‘Delay’ Apparatus with a Nephele-Miller Mixing Inlet Yield Similar Outcomes Testing a Pressurized Metered Dose Inhaler With Valved Holding Chamber (pMDI+VHC) Combination?
Trudell Medical International
Mark Nagel and Jolyon Mitchell
Exploring the Deposition Profile of Salbutamol Sulfate Delivered by Pressurized Metered Dose Inhaler Sampled Via Fast Screening Impactor (FSI)
Universidad de Valparaíso
Tania Bahamondez-Canas
Gelatin Microcapsules as a Platform to Increase Ciprofloxacin Efficacy Against Bacterial Biofilms
Universidad de Valparaíso
Daniel Moraga-Espinoza
Enhancing Extended-Release Profiles of Gelatin Microcapsules Using Ionotropic Gelation and Lipid Coating by Spray Drying
University of Alberta
Mani Ordoubadi
Improved Process and Particle Design in Spray Drying: Adding CFD Analysis to Particle Formation Models
University of Alberta
Mani Ordoubadi
L-Leucine as a Dispersibility Enhancer in Fully Crystalline Spray-Dried Systems
University of Alberta
Hui Wang
Droplet Characteristics of Low Global Warming Potential Propellants at Different Ambient Humidities
University of Applied Sciences Biberach
Janik Martin
Characterization of the Suitability of a Primary Cell Airway Model from the Porcine Trachea for Uptake and Permeation Studies and as a Potential Model for Mucociliary Clearance
University of Applied Sciences Biberach
Rebecca Rittersberger
Evaluation of a Novel Porcine Trachea Cell Airway Model for the Screening of Excipient Toxicity used in Biopharmaceutical Inhalation Products
University of Coimbra
Patricia Henriques
Benchmarking of Particle Engineering Strategies for Nasal Powder Delivery: Characterization of Nasal Deposition Using the Alberta Idealized Nasal Inlet
University of Coimbra
Patricia Henriques
In Vitro Methodologies for the Screening of Nasal Powders: Polymer-Based Formulations
University of Hertfordshire
Adeel Ahmed
Go with the Flow: Evaluation of a Perfused Calu-3 Model Using a Micro-Physiological System for Inhaled Drug Discovery
University of Otago
Rakesh Bastola and Shyamal Das
Influence of Lung Mucus on In Vitro Dissolution and Absorption of an Inhalable Drug
University of Parma
Francesca Buttini
A Roadmap for Constructing a Beclomethasone pMDI Solution Using HFA152a
University of Parma
Francesca Buttini
Rethinking Dose Delivery and Product Efficiency for the Sustainable Development of Generic DPIs
Upperton Pharma Solutions
Jordan Potts
Investigations into the Relationship Between Spray Dried Powder Particle Size and Deposition in Nose and Lung Analogues when Actuated from a Nasal Device
Vectura
Daniel Lock
Multi-Factor Understanding of Vibrating-Mesh Nebulization: Placing Patient Needs at the Center of the Combination Product Development Process
World Medicine
Cigdem Acar
Evaluation of the Impact of Polymorphic Forms of Lactose Having the Same Particle Size on Dry Powder Inhaler Aerodynamic Performance

Questions?

For further information, contact Richard Dalby.

↑ Back to Top